ArticleThe Journal of clinical investigation2022

Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.

Marine Besnard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.